Industry Research Reports

Home > Reports > Service & Software > Personalized Psychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Personalized Psychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Service & Software

Published Date: 2025-03-12

Pages: 84 Pages

Report ld: 4647401

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global market for Personalized Psychiatry was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

North American market for Personalized Psychiatry was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Personalized Psychiatry was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Personalized Psychiatry was valued at $ million in 2024 and will reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global key companies of Personalized Psychiatry include COMPASS Pathways, Mindstrong Health, Pear Therapeutics, Cogito, Kaia Health, Sooma, GenoMind, Empatica, Akili Interactive, Neuroverse, etc. In 2024, the global five largest players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Personalized Psychiatry, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Personalized Psychiatry by region & country, by Type, and by Application.

The Personalized Psychiatry market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Personalized Psychiatry.

MARKET SEGMENTATION

By Company

COMPASS Pathways
Mindstrong Health
Pear Therapeutics
Cogito
Kaia Health
Sooma
GenoMind
Empatica
Akili Interactive
Neuroverse

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Depression and Anxiety
Bipolar Disorder
Addiction
Other

Segment by Application

Mental Health Professionals
Patients
Healthcare Providers

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Personalized Psychiatry company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Personalized Psychiatry in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Personalized Psychiatry in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Personalized Psychiatry Product Introduction

1.2 Global Personalized Psychiatry Market Size Forecast (2020-2031)

1.3 Personalized Psychiatry Market Trends & Drivers

1.3.1 Personalized Psychiatry Industry Trends

1.3.2 Personalized Psychiatry Market Drivers & Opportunity

1.3.3 Personalized Psychiatry Market Challenges

1.3.4 Personalized Psychiatry Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Personalized Psychiatry Players Revenue Ranking (2024)

2.2 Global Personalized Psychiatry Revenue by Company (2020-2025)

2.3 Key Companies Personalized Psychiatry Manufacturing Base Distribution and Headquarters

2.4 Key Companies Personalized Psychiatry Product Offered

2.5 Key Companies Time to Begin Mass Production of Personalized Psychiatry

2.6 Personalized Psychiatry Market Competitive Analysis

2.6.1 Personalized Psychiatry Market Concentration Rate (2020-2025)

2.6.2 Global 5 and 10 Largest Companies by Personalized Psychiatry Revenue in 2024

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Psychiatry as of 2024)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Depression and Anxiety

3.1.2 Bipolar Disorder

3.1.3 Addiction

3.1.4 Other

3.2 Global Personalized Psychiatry Sales Value by Type

3.2.1 Global Personalized Psychiatry Sales Value by Type (2020 VS 2024 VS 2031)

3.2.2 Global Personalized Psychiatry Sales Value, by Type (2020-2031)

3.2.3 Global Personalized Psychiatry Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Mental Health Professionals

4.1.2 Patients

4.1.3 Healthcare Providers

4.2 Global Personalized Psychiatry Sales Value by Application

4.2.1 Global Personalized Psychiatry Sales Value by Application (2020 VS 2024 VS 2031)

4.2.2 Global Personalized Psychiatry Sales Value, by Application (2020-2031)

4.2.3 Global Personalized Psychiatry Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

5.1 Global Personalized Psychiatry Sales Value by Region

5.1.1 Global Personalized Psychiatry Sales Value by Region: 2020 VS 2024 VS 2031

5.1.2 Global Personalized Psychiatry Sales Value by Region (2020-2025)

5.1.3 Global Personalized Psychiatry Sales Value by Region (2026-2031)

5.1.4 Global Personalized Psychiatry Sales Value by Region (%), (2020-2031)

5.2 North America

5.2.1 North America Personalized Psychiatry Sales Value, 2020-2031

5.2.2 North America Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

5.3 Europe

5.3.1 Europe Personalized Psychiatry Sales Value, 2020-2031

5.3.2 Europe Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

5.4 Asia Pacific

5.4.1 Asia Pacific Personalized Psychiatry Sales Value, 2020-2031

5.4.2 Asia Pacific Personalized Psychiatry Sales Value by Region (%), 2024 VS 2031

5.5 South America

5.5.1 South America Personalized Psychiatry Sales Value, 2020-2031

5.5.2 South America Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

5.6 Middle East & Africa

5.6.1 Middle East & Africa Personalized Psychiatry Sales Value, 2020-2031

5.6.2 Middle East & Africa Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Personalized Psychiatry Sales Value Growth Trends, 2020 VS 2024 VS 2031

6.2 Key Countries/Regions Personalized Psychiatry Sales Value, 2020-2031

6.3 United States

6.3.1 United States Personalized Psychiatry Sales Value, 2020-2031

6.3.2 United States Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.3.3 United States Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.4 Europe

6.4.1 Europe Personalized Psychiatry Sales Value, 2020-2031

6.4.2 Europe Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.4.3 Europe Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.5 China

6.5.1 China Personalized Psychiatry Sales Value, 2020-2031

6.5.2 China Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.5.3 China Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.6 Japan

6.6.1 Japan Personalized Psychiatry Sales Value, 2020-2031

6.6.2 Japan Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.6.3 Japan Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.7 South Korea

6.7.1 South Korea Personalized Psychiatry Sales Value, 2020-2031

6.7.2 South Korea Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.7.3 South Korea Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.8 Southeast Asia

6.8.1 Southeast Asia Personalized Psychiatry Sales Value, 2020-2031

6.8.2 Southeast Asia Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.8.3 Southeast Asia Personalized Psychiatry Sales Value by Application, 2024 VS 2031

6.9 India

6.9.1 India Personalized Psychiatry Sales Value, 2020-2031

6.9.2 India Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

6.9.3 India Personalized Psychiatry Sales Value by Application, 2024 VS 2031

7 Company Profiles

7.1 COMPASS Pathways

7.1.1 COMPASS Pathways Profile

7.1.2 COMPASS Pathways Main Business

7.1.3 COMPASS Pathways Personalized Psychiatry Products, Services and Solutions

7.1.4 COMPASS Pathways Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.1.5 COMPASS Pathways Recent Developments

7.2 Mindstrong Health

7.2.1 Mindstrong Health Profile

7.2.2 Mindstrong Health Main Business

7.2.3 Mindstrong Health Personalized Psychiatry Products, Services and Solutions

7.2.4 Mindstrong Health Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.2.5 Mindstrong Health Recent Developments

7.3 Pear Therapeutics

7.3.1 Pear Therapeutics Profile

7.3.2 Pear Therapeutics Main Business

7.3.3 Pear Therapeutics Personalized Psychiatry Products, Services and Solutions

7.3.4 Pear Therapeutics Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.3.5 Pear Therapeutics Recent Developments

7.4 Cogito

7.4.1 Cogito Profile

7.4.2 Cogito Main Business

7.4.3 Cogito Personalized Psychiatry Products, Services and Solutions

7.4.4 Cogito Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.4.5 Cogito Recent Developments

7.5 Kaia Health

7.5.1 Kaia Health Profile

7.5.2 Kaia Health Main Business

7.5.3 Kaia Health Personalized Psychiatry Products, Services and Solutions

7.5.4 Kaia Health Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.5.5 Kaia Health Recent Developments

7.6 Sooma

7.6.1 Sooma Profile

7.6.2 Sooma Main Business

7.6.3 Sooma Personalized Psychiatry Products, Services and Solutions

7.6.4 Sooma Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.6.5 Sooma Recent Developments

7.7 GenoMind

7.7.1 GenoMind Profile

7.7.2 GenoMind Main Business

7.7.3 GenoMind Personalized Psychiatry Products, Services and Solutions

7.7.4 GenoMind Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.7.5 GenoMind Recent Developments

7.8 Empatica

7.8.1 Empatica Profile

7.8.2 Empatica Main Business

7.8.3 Empatica Personalized Psychiatry Products, Services and Solutions

7.8.4 Empatica Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.8.5 Empatica Recent Developments

7.9 Akili Interactive

7.9.1 Akili Interactive Profile

7.9.2 Akili Interactive Main Business

7.9.3 Akili Interactive Personalized Psychiatry Products, Services and Solutions

7.9.4 Akili Interactive Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.9.5 Akili Interactive Recent Developments

7.10 Neuroverse

7.10.1 Neuroverse Profile

7.10.2 Neuroverse Main Business

7.10.3 Neuroverse Personalized Psychiatry Products, Services and Solutions

7.10.4 Neuroverse Personalized Psychiatry Revenue (US$ Million) & (2020-2025)

7.10.5 Neuroverse Recent Developments

8 Industry Chain Analysis

8.1 Personalized Psychiatry Industrial Chain

8.2 Personalized Psychiatry Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Personalized Psychiatry Sales Model

8.5.2 Sales Channel

8.5.3 Personalized Psychiatry Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Personalized Psychiatry Market Trends

Table 2. Personalized Psychiatry Market Drivers & Opportunity

Table 3. Personalized Psychiatry Market Challenges

Table 4. Personalized Psychiatry Market Restraints

Table 5. Global Personalized Psychiatry Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Personalized Psychiatry Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Personalized Psychiatry Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Personalized Psychiatry Product Type

Table 9. Key Companies Time to Begin Mass Production of Personalized Psychiatry

Table 10. Global Personalized Psychiatry Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Personalized Psychiatry as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Personalized Psychiatry Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Personalized Psychiatry Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Personalized Psychiatry Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Personalized Psychiatry Sales Market Share in Value by Type (2020-2025)

Table 17. Global Personalized Psychiatry Sales Market Share in Value by Type (2026-2031)

Table 18. Global Personalized Psychiatry Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Personalized Psychiatry Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Personalized Psychiatry Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Personalized Psychiatry Sales Market Share in Value by Application (2020-2025)

Table 22. Global Personalized Psychiatry Sales Market Share in Value by Application (2026-2031)

Table 23. Global Personalized Psychiatry Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Personalized Psychiatry Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Personalized Psychiatry Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Personalized Psychiatry Sales Value by Region (2020-2025) & (%)

Table 27. Global Personalized Psychiatry Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Personalized Psychiatry Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Personalized Psychiatry Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Personalized Psychiatry Sales Value, (2026-2031) & (US$ Million)

Table 31. COMPASS Pathways Basic Information List

Table 32. COMPASS Pathways Description and Business Overview

Table 33. COMPASS Pathways Personalized Psychiatry Products, Services and Solutions

Table 34. Revenue (US$ Million) in Personalized Psychiatry Business of COMPASS Pathways (2020-2025)

Table 35. COMPASS Pathways Recent Developments

Table 36. Mindstrong Health Basic Information List

Table 37. Mindstrong Health Description and Business Overview

Table 38. Mindstrong Health Personalized Psychiatry Products, Services and Solutions

Table 39. Revenue (US$ Million) in Personalized Psychiatry Business of Mindstrong Health (2020-2025)

Table 40. Mindstrong Health Recent Developments

Table 41. Pear Therapeutics Basic Information List

Table 42. Pear Therapeutics Description and Business Overview

Table 43. Pear Therapeutics Personalized Psychiatry Products, Services and Solutions

Table 44. Revenue (US$ Million) in Personalized Psychiatry Business of Pear Therapeutics (2020-2025)

Table 45. Pear Therapeutics Recent Developments

Table 46. Cogito Basic Information List

Table 47. Cogito Description and Business Overview

Table 48. Cogito Personalized Psychiatry Products, Services and Solutions

Table 49. Revenue (US$ Million) in Personalized Psychiatry Business of Cogito (2020-2025)

Table 50. Cogito Recent Developments

Table 51. Kaia Health Basic Information List

Table 52. Kaia Health Description and Business Overview

Table 53. Kaia Health Personalized Psychiatry Products, Services and Solutions

Table 54. Revenue (US$ Million) in Personalized Psychiatry Business of Kaia Health (2020-2025)

Table 55. Kaia Health Recent Developments

Table 56. Sooma Basic Information List

Table 57. Sooma Description and Business Overview

Table 58. Sooma Personalized Psychiatry Products, Services and Solutions

Table 59. Revenue (US$ Million) in Personalized Psychiatry Business of Sooma (2020-2025)

Table 60. Sooma Recent Developments

Table 61. GenoMind Basic Information List

Table 62. GenoMind Description and Business Overview

Table 63. GenoMind Personalized Psychiatry Products, Services and Solutions

Table 64. Revenue (US$ Million) in Personalized Psychiatry Business of GenoMind (2020-2025)

Table 65. GenoMind Recent Developments

Table 66. Empatica Basic Information List

Table 67. Empatica Description and Business Overview

Table 68. Empatica Personalized Psychiatry Products, Services and Solutions

Table 69. Revenue (US$ Million) in Personalized Psychiatry Business of Empatica (2020-2025)

Table 70. Empatica Recent Developments

Table 71. Akili Interactive Basic Information List

Table 72. Akili Interactive Description and Business Overview

Table 73. Akili Interactive Personalized Psychiatry Products, Services and Solutions

Table 74. Revenue (US$ Million) in Personalized Psychiatry Business of Akili Interactive (2020-2025)

Table 75. Akili Interactive Recent Developments

Table 76. Neuroverse Basic Information List

Table 77. Neuroverse Description and Business Overview

Table 78. Neuroverse Personalized Psychiatry Products, Services and Solutions

Table 79. Revenue (US$ Million) in Personalized Psychiatry Business of Neuroverse (2020-2025)

Table 80. Neuroverse Recent Developments

Table 81. Key Raw Materials Lists

Table 82. Raw Materials Key Suppliers Lists

Table 83. Personalized Psychiatry Downstream Customers

Table 84. Personalized Psychiatry Distributors List

Table 85. Research Programs/Design for This Report

Table 86. Key Data Information from Secondary Sources

Table 87. Key Data Information from Primary Sources

List of Figures

Figure 1. Personalized Psychiatry Product Picture

Figure 2. Global Personalized Psychiatry Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Personalized Psychiatry Sales Value (2020-2031) & (US$ Million)

Figure 4. Personalized Psychiatry Report Years Considered

Figure 5. Global Personalized Psychiatry Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Personalized Psychiatry Revenue in 2024

Figure 7. Personalized Psychiatry Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Depression and Anxiety Picture

Figure 9. Bipolar Disorder Picture

Figure 10. Addiction Picture

Figure 11. Other Picture

Figure 12. Global Personalized Psychiatry Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 13. Global Personalized Psychiatry Sales Value Market Share by Type, 2024 & 2031

Figure 14. Product Picture of Mental Health Professionals

Figure 15. Product Picture of Patients

Figure 16. Product Picture of Healthcare Providers

Figure 17. Global Personalized Psychiatry Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 18. Global Personalized Psychiatry Sales Value Market Share by Application, 2024 & 2031

Figure 19. North America Personalized Psychiatry Sales Value (2020-2031) & (US$ Million)

Figure 20. North America Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

Figure 21. Europe Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 22. Europe Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

Figure 23. Asia Pacific Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 24. Asia Pacific Personalized Psychiatry Sales Value by Region (%), 2024 VS 2031

Figure 25. South America Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 26. South America Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

Figure 27. Middle East & Africa Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 28. Middle East & Africa Personalized Psychiatry Sales Value by Country (%), 2024 VS 2031

Figure 29. Key Countries/Regions Personalized Psychiatry Sales Value (%), (2020-2031)

Figure 30. United States Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 31. United States Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 32. United States Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 33. Europe Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 34. Europe Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 35. Europe Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 36. China Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 37. China Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 38. China Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 39. Japan Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 40. Japan Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 41. Japan Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 42. South Korea Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 43. South Korea Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 44. South Korea Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 45. Southeast Asia Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 46. Southeast Asia Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 47. Southeast Asia Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 48. India Personalized Psychiatry Sales Value, (2020-2031) & (US$ Million)

Figure 49. India Personalized Psychiatry Sales Value by Type (%), 2024 VS 2031

Figure 50. India Personalized Psychiatry Sales Value by Application (%), 2024 VS 2031

Figure 51. Personalized Psychiatry Industrial Chain

Figure 52. Personalized Psychiatry Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Personalized Psychiatry market? zhanKai

The top companies in the global Personalized Psychiatry market are COMPASS Pathways、Mindstrong Health、Pear Therapeutics.

Related Reports

Global Personalized Psychiatry Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-26
Pages: 121
USD 4900.00
(Single User License)
Global Personalized Psychiatry Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 78
USD 4250.00
(Single User License)
Personalized Psychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-19
Pages: 89
USD 3950.00
(Single User License)
Global Personalized Psychiatry Market Research Report 2026
The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 101
USD 2900.00
(Single User License)
Global Personalized Psychiatry Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-06
Pages: 76
USD 4250.00
(Single User License)
Global Personalized Psychiatry Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-08-05
Pages: 126
USD 4900.00
(Single User License)
Global Personalized Psychiatry Market Research Report 2025
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-12
Pages: 80
USD 2900.00
(Single User License)
Global and United States Personalized Psychiatry Market Report & Forecast 2024-2030
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published Date: 2024-08-01
Pages: 93
USD 4350.00
(Single User License)
Global Personalized Psychiatry Market Research Report 2024
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published Date: 2024-08-01
Pages: 71
USD 2900.00
(Single User License)
Global Personalized Psychiatry Market Insights, Forecast to 2030
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published Date: 2024-08-01
Pages: 128
USD 4900.00
(Single User License)

Global Personalized Psychiatry Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Personalized Psychiatry market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-26
Pages: 121
USD 4900.00 (Single User License)
Global Personalized Psychiatry Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Personalized Psychiatry market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 78
USD 4250.00 (Single User License)
Personalized Psychiatry - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Personalized Psychiatry was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-19
Pages: 89
USD 3950.00 (Single User License)
Global Personalized Psychiatry Market Research Report 2026
The global Personalized Psychiatry market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 101
USD 2900.00 (Single User License)
Global Personalized Psychiatry Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Personalized Psychiatry market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-06
Pages: 76
USD 4250.00 (Single User License)
Global Personalized Psychiatry Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-08-05
Pages: 126
USD 4900.00 (Single User License)
Global Personalized Psychiatry Market Research Report 2025
The global market for Personalized Psychiatry was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-12
Pages: 80
USD 2900.00 (Single User License)
Global and United States Personalized Psychiatry Market Report & Forecast 2024-2030
The global Personalized Psychiatry revenue was US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of %during the review period (2024-2030).
Published: 2024-08-01
Pages: 93
USD 4350.00 (Single User License)
Global Personalized Psychiatry Market Research Report 2024
The global Personalized Psychiatry market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
Published: 2024-08-01
Pages: 71
USD 2900.00 (Single User License)
Global Personalized Psychiatry Market Insights, Forecast to 2030
The global Personalized Psychiatry market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of %during the forecast period.
Published: 2024-08-01
Pages: 128
USD 4900.00 (Single User License)